# Study of the Immunoresponse in Patients Treated With a Tyrosine Kinase Inhibitor

> **NCT00979381** · — · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 75 (actual)

## Conditions studied

- Renal Cell Carcinoma
- GIST

## Interventions

- **BIOLOGICAL:** influenza vaccine

## Key facts

- **NCT ID:** NCT00979381
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2008-11
- **Final completion:** 2009-11
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2010-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00979381

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00979381, "Study of the Immunoresponse in Patients Treated With a Tyrosine Kinase Inhibitor". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00979381. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*